◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Profound Medical Corp.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Total Revenue 5.3M 2.2M 2.6M 3.7M 2.8M --
Operating Revenue 5.3M 2.2M 2.6M 3.7M 2.8M --
Cost Of Revenue 1.4M 593,000 768,000 1.2M 1.0M --
Gross Profit 3.9M 1.6M 1.9M 2.5M 1.8M --
Selling General And Administration 7.4M 9.3M 8.2M 6.6M 6.6M --
General And Administrative Expense 7.4M -- -- -- 6.6M 2.1M
Research And Development 5.4M 6.1M 4.8M 4.7M 4.2M --
Operating Expense 12.8M 15.4M 13.0M 11.3M 10.8M --
Operating Income -8.9M -13.8M -11.2M -8.8M -9.0M --
EBIT -8.9M -13.8M -11.2M -8.8M -9.0M --
Interest Expense -- -- -- -- 199,000 --
Interest Expense Non Operating -- -- -- -- 199,000 --
Net Interest Income 122,000 343,000 445,000 -621,000 220,000 --
Other Income Expense 935,000 -2.2M 38,000 -- -410,000 520,000
Gain On Sale Of Security 935,000 -2.2M 38,000 -- -410,000 520,000
Pretax Income -7.9M -15.6M -10.7M -5.6M -9.2M --
Tax Provision 121,000 64,000 41,000 -238,000 177,000 --
Tax Effect Of Unusual Items 140,250 -325,200 5,700 0.00 -61,500 --
Net Income From Continuing And Discontinued Operation -8.0M -15.7M -10.7M -5.3M -9.4M --
Net Income From Continuing Operation Net Minority Interest -8.0M -15.7M -10.7M -5.3M -9.4M --
Net Income Including Noncontrolling Interests -8.0M -15.7M -10.7M -5.3M -9.4M --
Net Income Common Stockholders -8.0M -15.7M -10.7M -5.3M -9.4M --
Net Income -8.0M -15.7M -10.7M -5.3M -9.4M --
EBITDA -8.8M -13.7M -11.0M -8.7M -8.8M --
Normalized EBITDA -9.7M -11.5M -11.0M -8.7M -8.4M --
Reconciled Depreciation 147,000 141,000 163,000 76,000 214,000 --
Basic EPS -0.26 -0.52 -0.36 -0.20 -0.38 --
Diluted EPS -0.26 -0.52 -0.36 -0.20 -0.38 --
Basic Average Shares 30.1M 30.1M 30.0M 25.8M 24.5M --
Diluted Average Shares 30.1M 30.1M 30.0M 25.8M 24.5M --
Total Unusual Items 935,000 -2.2M 38,000 -- -410,000 520,000
Total Unusual Items Excluding Goodwill 935,000 -2.2M 38,000 -- -410,000 520,000
Tax Rate For Calcs 0.15 0.15 0.15 0.04 0.15 --
Normalized Income -8.8M -13.9M -10.8M -5.3M -9.0M --
Diluted NI Availto Com Stockholders -8.0M -15.7M -10.7M -5.3M -9.4M --
Net Income Continuous Operations -8.0M -15.7M -10.7M -5.3M -9.4M --
Net Non Operating Interest Income Expense 122,000 343,000 445,000 -621,000 220,000 --
Other Gand A 7.4M -- -- -- 6.6M 2.1M
Reconciled Cost Of Revenue 1.4M 593,000 768,000 1.2M 1.0M --
Selling And Marketing Expense -- -- -- -- 2.9M 3.0M
Total Expenses 14.2M 16.0M 13.8M 12.5M 11.8M --
Total Operating Income As Reported -8.9M -13.8M -11.2M -8.8M -9.0M --
Total Other Finance Cost -122,000 -343,000 -445,000 -- -220,000 -422,000
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Cash And Cash Equivalents 24.8M 35.2M 46.4M 54.9M 27.1M --
Cash Cash Equivalents And Short Term Investments 24.8M 35.2M 46.4M 54.9M 27.1M --
Cash Financial 24.8M 35.2M 46.4M 54.9M 27.1M --
Accounts Receivable 7.5M 4.1M 4.8M 6.6M 7.0M --
Receivables 8.2M 4.9M 6.0M 7.0M 7.0M --
Inventory 8.3M 8.4M 6.8M 5.8M 6.4M --
Prepaid Assets 195,000 365,000 718,000 1.3M 296,000 --
Current Assets 41.5M 48.8M 59.9M 69.1M 40.9M --
Gross PPE 2.2M 2.5M 2.6M 3.2M 1.0M --
Accumulated Depreciation -1.6M -1.9M -1.9M -2.4M -- --
Net PPE 578,000 581,000 651,000 821,010 1.0M --
Goodwill And Other Intangible Assets 123,000 175,000 214,000 261,000 329,000 --
Other Intangible Assets 123,000 175,000 214,000 261,000 329,000 --
Total Non Current Assets 781,000 857,000 952,000 1.2M 1.4M --
Total Assets 42.3M 49.7M 60.9M 70.2M 42.2M --
Current Debt 4.5M -- -- 1.7M 2.2M 2.0M
Current Debt And Capital Lease Obligation 4.8M 279,000 261,000 2.0M 2.5M --
Accounts Payable 717,000 949,000 1.0M 1.3M 3.4M --
Payables 775,000 949,000 1.0M 1.3M 3.4M --
Payables And Accrued Expenses 1.4M 1.5M 2.0M 3.1M 3.4M --
Current Accrued Expenses 630,000 509,000 955,000 1.8M -- --
Current Deferred Revenue 434,000 694,000 636,000 419,000 801,000 --
Other Current Liabilities 1.1M 1.3M 423,000 325,000 -- --
Current Liabilities 9.9M 5.7M 5.3M 6.6M 6.7M --
Long Term Debt -- 4.5M 4.5M 2.9M 3.4M 3.9M
Long Term Debt And Capital Lease Obligation 0.00 4.5M 4.6M 3.1M 3.8M --
Long Term Capital Lease Obligation 0.00 72,000 136,000 203,000 365,000 --
Other Non Current Liabilities 76,000 77,000 72,000 71,000 -- --
Total Non Current Liabilities Net Minority Interest 224,000 4.7M 4.8M 3.2M 4.5M --
Total Liabilities Net Minority Interest 10.2M 10.4M 10.1M 9.8M 11.2M --
Common Stock 282.8M 281.6M 281.6M 281.6M 235.7M --
Capital Stock 282.8M 281.6M 281.6M 281.6M 235.7M --
Additional Paid In Capital 24.2M 23.6M 22.2M 21.3M 19.4M --
Retained Earnings -279.6M -271.6M -255.9M -245.2M -240.4M --
Gains Losses Not Affecting Retained Earnings 4.8M 5.6M 2.8M 2.7M 16.4M --
Other Equity Adjustments 4.8M 5.6M 2.8M 2.7M 16.4M --
Common Stock Equity 32.1M 39.3M 50.8M 60.4M 31.1M --
Stockholders Equity 32.1M 39.3M 50.8M 60.4M 31.1M --
Total Equity Gross Minority Interest 32.1M 39.3M 50.8M 60.4M 31.1M --
Total Capitalization 32.1M 43.7M 55.3M 63.3M 34.5M --
Net Tangible Assets 32.0M 39.1M 50.6M 60.2M 30.7M --
Tangible Book Value 32.0M 39.1M 50.6M 60.2M 30.7M --
Working Capital 31.6M 43.1M 54.6M 62.5M 34.2M --
Invested Capital 36.6M 43.7M 55.3M 65.1M 36.7M --
Total Debt 4.8M 4.8M 4.9M 5.1M 6.2M --
Share Issued 30.2M 30.1M 30.1M 30.0M 24.7M --
Ordinary Shares Number 30.2M 30.1M 30.1M 30.0M 24.7M --
Allowance For Doubtful Accounts Receivable -- -- -- -158,000 -- --
Capital Lease Obligations 277,000 351,000 397,000 460,000 630,000 --
Current Capital Lease Obligation 277,000 279,000 261,000 257,000 265,000 --
Current Deferred Liabilities 434,000 694,000 636,000 419,000 801,000 --
Finished Goods 5.8M 5.6M 4.6M 3.8M -- --
Gross Accounts Receivable 7.5M 4.1M 4.8M 6.6M -- --
Income Tax Payable 58,000 -- -- -- 15,000 --
Leases 542,000 542,000 542,000 542,000 -- --
Non Current Deferred Assets 80,000 101,000 87,000 87,000 -- --
Non Current Deferred Liabilities 148,000 74,000 85,000 49,000 731,000 --
Non Current Deferred Revenue 148,000 74,000 85,000 49,000 672,000 --
Non Current Deferred Taxes Assets 80,000 101,000 87,000 87,000 -- --
Non Current Deferred Taxes Liabilities -- -- -- 0.00 59,000 59,000
Other Current Borrowings 4.5M -- -- 1.7M 2.2M 2.0M
Other Properties 1.6M 1.9M 2.0M 2.7M 1.0M --
Other Receivables 498,000 758,000 740,000 310,000 -- --
Pensionand Other Post Retirement Benefit Plans Current 2.2M 2.0M 2.0M 706,000 -- --
Properties 0.00 0.00 0.00 0.00 -- --
Raw Materials 2.5M 2.7M 2.2M 2.0M -- --
Receivables Adjustments Allowances -624,000 -531,000 -105,000 -158,000 -- --
Taxes Receivable 746,000 557,000 499,000 308,000 -- --
Total Tax Payable 58,000 -- -- -- 15,000 --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Operating Cash Flow -9.6M -13.7M -8.3M -5.6M -6.8M --
Cash Flow From Continuing Operating Activities -9.6M -13.7M -8.3M -5.6M -6.8M --
Depreciation And Amortization 147,000 141,000 163,000 76,000 214,000 --
Depreciation Amortization Depletion 147,000 141,000 163,000 76,000 214,000 --
Stock Based Compensation 1.7M 1.5M 989,000 442,000 604,000 --
Change In Working Capital -3.5M 366,000 1.2M -766,000 1.7M --
Change In Receivables -3.4M 1.4M 1.1M -124,000 297,000 --
Change In Inventory 130,000 -1.7M -984,000 475,000 344,000 --
Change In Payables And Accrued Expense -149,000 245,000 300,000 639,000 690,000 --
Change In Payable -149,000 245,000 300,000 639,000 690,000 --
Change In Other Working Capital -192,000 51,000 252,000 -647,000 47,000 --
Other Non Cash Items -2,000 -7,000 39,000 -60,000 60,000 --
Repayment Of Debt 0.00 0.00 -290,000 -523,000 -592,000 --
Net Issuance Payments Of Debt 0.00 0.00 -290,000 -523,000 -592,000 --
Issuance Of Capital Stock 0.00 0.00 0.00 39.2M 0.00 --
Net Common Stock Issuance 0.00 0.00 0.00 39.2M 0.00 --
Financing Cash Flow 0.00 0.00 -290,000 35.7M -592,000 --
Cash Flow From Continuing Financing Activities 0.00 0.00 -290,000 35.7M -592,000 --
Effect Of Exchange Rate Changes -755,000 2.5M 94,000 -2.2M 462,000 --
Changes In Cash -9.6M -13.7M -8.6M 30.0M -7.4M --
Beginning Cash Position 35.2M 46.4M 54.9M 27.1M 34.1M --
End Cash Position 24.8M 35.2M 46.4M 54.9M 27.1M --
Free Cash Flow -9.6M -13.7M -8.3M -5.6M -6.8M --
Income Tax Paid Supplemental Data 35,000 54,000 11,000 -- 38,000 160,000
Interest Paid Supplemental Data 112,000 83,000 56,000 -- 133,000 148,000
Amortization Cash Flow 54,000 39,000 47,000 78,000 50,000 --
Amortization Of Intangibles 54,000 39,000 47,000 78,000 50,000 --
Change In Account Payable -207,000 245,000 300,000 653,000 676,000 --
Change In Income Tax Payable -- -- 0.00 -14,000 14,000 -14,000
Change In Prepaid Assets 116,000 450,000 592,000 -1.1M 283,000 --
Change In Tax Payable -- -- 0.00 -14,000 14,000 -14,000
Common Stock Issuance 0.00 0.00 0.00 39.2M 0.00 --
Depreciation 93,000 102,000 116,000 -2,000 164,000 --
Long Term Debt Payments 0.00 0.00 -290,000 -523,000 -592,000 --
Net Income From Continuing Operations -8.0M -15.7M -10.7M -5.3M -9.4M --
Net Long Term Debt Issuance 0.00 0.00 -290,000 -523,000 -592,000 --
Net Other Financing Charges -- -- -- -3.0M 0.00 0.00
Proceeds From Stock Option Exercised 0.00 -- -- 44,000 0.00 1,000
NEWS
Loading news...
TRENDING
Loading...